![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire](https://mms.businesswire.com/media/20201005005212/en/826961/5/AermonyRespiClick_ENG.jpg)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
![Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis - European Medical Journal Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/09/Figure-1-How-Eupraxias-particle-release-technology-works-940x470.jpg)
Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis - European Medical Journal
![Pulmonary & Nasal Drug Delivery - ONdrugDelivery - Issue 140 - November 2022 by ONdrugDelivery Magazine - Issuu Pulmonary & Nasal Drug Delivery - ONdrugDelivery - Issue 140 - November 2022 by ONdrugDelivery Magazine - Issuu](https://image.isu.pub/221123200923-6ad10945db4db3d6a43e0a6f2760ec70/jpg/page_1.jpg)
Pulmonary & Nasal Drug Delivery - ONdrugDelivery - Issue 140 - November 2022 by ONdrugDelivery Magazine - Issuu
![Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis - Journal of Allergy and Clinical Immunology Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis - Journal of Allergy and Clinical Immunology](https://www.jacionline.org/cms/asset/3199fe11-52ca-4cb5-b77d-8d9cd681af17/fx1.jpg)
Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis - Journal of Allergy and Clinical Immunology
![Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma - Annals of Allergy, Asthma & Immunology Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma - Annals of Allergy, Asthma & Immunology](https://www.annallergy.org/cms/asset/b9a6bc7b-d2a2-48a2-b9f1-30895cd2c023/gr1.jpg)
Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma - Annals of Allergy, Asthma & Immunology
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® ( fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® ( fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20200921005170/en/819864/5/Interactive_Media_Placeholder_highres.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® ( fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® ( fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® ( fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20200921005170/en/820285/4/TEVA_DH-ArmonAir_Inhaler_TiltR_W.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® ( fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
![Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter A. Lio, Anju T. Peters, Michael P. Platt, Andrew A Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter A. Lio, Anju T. Peters, Michael P. Platt, Andrew A](https://journals.sagepub.com/cms/10.1177/0194599820965233/asset/images/large/10.1177_0194599820965233-fig4.jpeg)
Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter A. Lio, Anju T. Peters, Michael P. Platt, Andrew A
![Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation - Journal of Pharmaceutical Sciences Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/2046471739/2057555417/gr1.jpg)